Alpha Tau enters sponsored research agreement with MD Anderson to study Alpha DaRT in breast cancer Jan. 21, 2022
AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer Jan. 17, 2022
Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19 Jan. 14, 2022
RSS